GlaxoSmithKline Pharmaceuticals Ltd banner

GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 515.8999 INR -0.06% Market Closed
Market Cap: ₹426.2B

Intrinsic Value

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 376.6486 INR. Compared to the current market price of 2 515.8999 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 45%.

GLAXO Intrinsic Value
1 376.6486 INR
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
GlaxoSmithKline Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about GLAXO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GLAXO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for GlaxoSmithKline Pharmaceuticals Ltd.

Explain Valuation
Alternatives to GLAXO

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one GLAXO stock?

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 376.6486 INR.

Is GLAXO stock undervalued or overvalued?

Compared to the current market price of 2 515.8999 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 45%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett